Market Analysis and Insights:
Due to the COVID-19 pandemic, the global Vascular Closure Devices market size was value at US$ 1,036.88 million in 2021 and is forecast to be a readjusted size of US$ 1,735.13 million by 2028 with a CAGR of 7.74% during the forecast period 2022-2028.
The global main manufacturers of Vascular Closure Devices include Abbott Laboratories, Terumo Corporation, Cordis, Morrris Innovative, Teleflex Incorporated, and etc. In 2021, the global five largest players have a share approximately 93.94% in terms of revenue.
The North America Vascular Closure Devices market size was US$ 461.17 million in 2021, while China was about US$ 124.15 million. The proportion of the China was 11.97% in 2021 and it is predicted that the share will reach 19.66% in 2028, trailing a CAGR of 15.83% through the analysis period. As for the Europe Vascular Closure Devices landscape, Germany is projected to reach US$ 80.72 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 6.57% and 6.44% respectively for the next 6-year period.
Fully considering the economic change by the COVID-19, 8F accounting for 20.86% of the Vascular Closure Devices global market in 2021, is projected to value US$ 376.87 million by 2028, growing at a revised 8.32% CAGR from 2022 to 2028. While Interventional Procedures segment is altered to an 7.81% CAGR throughout this forecast period and will hold a share about 89.60% in 2028.
Scope and Market Size:
The global Vascular Closure Devices market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Vascular Closure Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
By Company
- Abbott Laboratories
- Terumo Corporation
- Cordis
- Teleflex Incorporated
- Morrris Innovative
Segment by Type
- 5F
- 6F
- 7F
- 8F
- 9F
- 10F
- 11F
- 12F
- 13F
- 14F
- 15F
- 16F
- 17F
- 18F
- 19F
- 20F
- 21F
- Others
Segment by Application
- Angiography Surgery
- Interventional Procedures
By Region
- Asia-Pacific
- China
- Japan
- Korea
- India
- Taiwan
- Southeast Asia
- Australia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
TABLE OF CONTENTS
1 VASCULAR CLOSURE DEVICES MARKET OVERVIEW
- 1.1 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW
- 1.2 VASCULAR CLOSURE DEVICES MARKET SEGMENT BY TYPE
- 1.2.1 5F
- 1.2.2 6F
- 1.2.3 7F
- 1.2.4 8F
- 1.2.5 9F
- 1.2.6 10F
- 1.2.7 11F
- 1.2.8 12F
- 1.2.9 13F
- 1.2.10 14F
- 1.2.11 15F
- 1.2.12 16F
- 1.2.13 17F
- 1.2.14 18F
- 1.2.15 19F
- 1.2.16 20F
- 1.2.17 21F
- 1.2.18 OTHERS
- 1.3 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE BY TYPE
- 1.3.1 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE OVERVIEW BY TYPE (2017-2028)
- 1.3.2 GLOBAL VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
- 1.3.3 GLOBAL VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY TYPE (2023-2028)
- 1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
- 1.4.1 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.2 EUROPE VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.3 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.4 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.5 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022)
2 VASCULAR CLOSURE DEVICES MARKET COMPETITION BY COMPANY
- 2.1 GLOBAL TOP PLAYERS BY VASCULAR CLOSURE DEVICES SALES (2019-2022)
- 2.2 GLOBAL TOP PLAYERS BY VASCULAR CLOSURE DEVICES REVENUE (2019-2022)
- 2.3 GLOBAL TOP PLAYERS BY VASCULAR CLOSURE DEVICES PRICE (2019-2022)
- 2.4 GLOBAL TOP MANUFACTURERS VASCULAR CLOSURE DEVICES HEADQUARTERS, SALES AREA
- 2.5 VASCULAR CLOSURE DEVICES MARKET COMPETITIVE SITUATION AND TRENDS
- 2.5.1 VASCULAR CLOSURE DEVICES MARKET CONCENTRATION RATE (2019-2022)
- 2.5.2 GLOBAL 3 AND 5 LARGEST MANUFACTURERS BY VASCULAR CLOSURE DEVICES REVENUE IN 2021
- 2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN VASCULAR CLOSURE DEVICES AS OF 2021)
- 2.7 ESTABLISHED DATE OF KEY VASCULAR CLOSURE DEVICES MANUFACTURERS
- 2.8 KEY MANUFACTURERS VASCULAR CLOSURE DEVICES PRODUCT OFFERED
- 2.9 MERGERS & ACQUISITIONS, EXPANSION
3 VASCULAR CLOSURE DEVICES STATUS AND OUTLOOK BY REGION
- 3.1 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028
- 3.2 GLOBAL VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY REGION
- 3.2.1 GLOBAL VASCULAR CLOSURE DEVICES SALES IN VOLUME BY REGION (2017-2022)
- 3.2.2 GLOBAL VASCULAR CLOSURE DEVICES SALES IN VALUE BY REGION (2017-2022)
- 3.2.3 GLOBAL VASCULAR CLOSURE DEVICES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2017-2022)
- 3.3 GLOBAL VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY REGION
- 3.3.1 GLOBAL VASCULAR CLOSURE DEVICES SALES IN VOLUME BY REGION (2023-2028)
- 3.3.2 GLOBAL VASCULAR CLOSURE DEVICES SALES IN VALUE BY REGION (2023-2028)
- 3.3.3 GLOBAL VASCULAR CLOSURE DEVICES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2023-2028)
4 VASCULAR CLOSURE DEVICES BY APPLICATION
- 4.1 VASCULAR CLOSURE DEVICES MARKET SEGMENT BY APPLICATION
- 4.1.1 ANGIOGRAPHY SURGERY
- 4.1.2 INTERVENTIONAL PROCEDURES
- 4.2 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE BY APPLICATION
- 4.2.1 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
- 4.2.2 GLOBAL VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
- 4.2.3 GLOBAL VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
- 4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
- 4.3.1 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.2 EUROPE VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.3 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.4 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.5 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022)
5 NORTH AMERICA VASCULAR CLOSURE DEVICES BY COUNTRY
- 5.1 NORTH AMERICA VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY COUNTRY
- 5.1.1 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2017-2022)
- 5.1.2 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2017-2022)
- 5.2 NORTH AMERICA VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY COUNTRY
- 5.2.1 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2023-2028)
- 5.2.2 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2023-2028)
6 EUROPE VASCULAR CLOSURE DEVICES BY COUNTRY
- 6.1 EUROPE VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY COUNTRY
- 6.1.1 EUROPE VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2017-2022)
- 6.1.2 EUROPE VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2017-2022)
- 6.2 EUROPE VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY COUNTRY
- 6.2.1 EUROPE VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2023-2028)
- 6.2.2 EUROPE VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2023-2028)
7 ASIA-PACIFIC VASCULAR CLOSURE DEVICES BY REGION
- 7.1 ASIA-PACIFIC VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY REGION
- 7.1.1 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES IN VOLUME BY REGION (2017-2022)
- 7.1.2 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES IN VALUE BY REGION (2017-2022)
- 7.2 ASIA-PACIFIC VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY REGION
- 7.2.1 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES IN VOLUME BY REGION (2023-2028)
- 7.2.2 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES IN VALUE BY REGION (2023-2028)
8 LATIN AMERICA VASCULAR CLOSURE DEVICES BY COUNTRY
- 8.1 LATIN AMERICA VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY COUNTRY
- 8.1.1 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2017-2022)
- 8.1.2 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2017-2022)
- 8.2 LATIN AMERICA VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY COUNTRY
- 8.2.1 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2023-2028)
- 8.2.2 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2023-2028)
9 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES BY COUNTRY
- 9.1 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY COUNTRY
- 9.1.1 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2017-2022)
- 9.1.2 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2017-2022)
- 9.2 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY COUNTRY
- 9.2.1 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2023-2028)
- 9.2.2 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2023-2028)
10 COMPANY PROFILES AND KEY FIGURES IN VASCULAR CLOSURE DEVICES BUSINESS
- 10.1 ABBOTT LABORATORIES
- 10.1.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
- 10.1.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW
- 10.1.3 ABBOTT LABORATORIES VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022)
- 10.1.4 MAIN BUSINESS/BUSINESS OVERVIEW
- 10.2 TERUMO CORPORATION
- 10.2.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
- 10.2.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW
- 10.2.3 TERUMO CORPORATION VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022)
- 10.2.4 MAIN BUSINESS/BUSINESS OVERVIEW
- 10.3 CORDIS
- 10.3.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
- 10.3.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW
- 10.3.3 CORDIS VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022)
- 10.3.4 MAIN BUSINESS/BUSINESS OVERVIEW
- 10.4 TELEFLEX INCORPORATED
- 10.4.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
- 10.4.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW
- 10.4.3 TELEFLEX INCORPORATED VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022)
- 10.4.4 MAIN BUSINESS/BUSINESS OVERVIEW
- 10.5 MORRRIS INNOVATIVE
- 10.5.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
- 10.5.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW
- 10.5.3 MORRRIS INNOVATIVE VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022)
- 10.5.4 MAIN BUSINESS/BUSINESS OVERVIEW
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
- 11.1 VASCULAR CLOSURE DEVICES KEY RAW MATERIALS
- 11.1.1 KEY RAW MATERIALS
- 11.1.2 RAW MATERIALS KEY SUPPLIERS
- 11.2 MANUFACTURING COST STRUCTURE
- 11.2.1 RAW MATERIALS
- 11.2.2 LABOR COST
- 11.2.3 MANUFACTURING EXPENSES
- 11.3 VASCULAR CLOSURE DEVICES INDUSTRIAL CHAIN ANALYSIS
- 11.4 VASCULAR CLOSURE DEVICES MARKET DYNAMICS
- 11.4.1 VASCULAR CLOSURE DEVICES INDUSTRY TRENDS
- 11.4.2 VASCULAR CLOSURE DEVICES MARKET DRIVERS
- 11.4.3 VASCULAR CLOSURE DEVICES MARKET CHALLENGES
- 11.4.4 PORTER'S FIVE FORCES ANALYSIS
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
- 12.1 SALES CHANNEL
- 12.2 VASCULAR CLOSURE DEVICES DISTRIBUTORS
- 12.3 VASCULAR CLOSURE DEVICES DOWNSTREAM CUSTOMERS
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
- 14.1 RESEARCH METHODOLOGY
- 14.1.1 METHODOLOGY/RESEARCH APPROACH
- 14.1.2 DATA SOURCE
- 14.2 AUTHOR DETAILS
- 14.3 DISCLAIMER